Metraipolis › archive › dc_ac2491cbb4bf

A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults — Europe PMC PMID:41313671

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41313671
DOI: 10.1093/infdis/jiaf571
License (as archived): solo-consultazione
Archived: 2026-11-05T11:44:12.171Z
SHA-256 of the archived text: 3a55d208f31ce1b298ef492018910d46076a5fba8d8a5eb9705aacff3e789eeb
Stable URL of this page: https://metraipolis.com/documento/dc_ac2491cbb4bf

How to cite

A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults — Europe PMC PMID:41313671 — Europe PMC (en), https://europepmc.org/article/MED/41313671 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ac2491cbb4bf (Metraipolis archive dc_ac2491cbb4bf, sha256 3a55d208f31ce1b298ef492018910d46076a5fba8d8a5eb9705aacff3e789eeb)

BibTeX

@misc{dcac2491cbb4bf,
  title = {A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults — Europe PMC PMID:41313671},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41313671},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ac2491cbb4bf; sha256 3a55d208f31ce1b298ef492018910d46076a5fba8d8a5eb9705aacff3e789eeb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41313671. Agents can read the archived copy with the MCP tool read_document.